Liquid pharmaceutical composition for nasal administration containing a polypeptide as active ingredient
US5124315A · kind A · utility
32Cited by
10References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 17, 1991 |
| Grant date | Jun 23, 1992 |
| Priority date | — |
| Expiry date | Jun 17, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A liquid composition for nasal administration of polypeptide/s containing ammonium tartrate and a buffer together with optional adiuvants.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.